Ignite Creation Date:
2024-05-05 @ 5:24 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00442585
Status:
COMPLETED
Last Update Posted:
2012-03-13
First Post:
2007-03-01
Brief Title:
S-Ibuprofen Effects on Asprin Treated Volunteers
Sponsor:
Gebro Pharma GmbH
Organization:
Gebro Pharma GmbH
Study Overview
Official Title:
Double Blind Randomised Parallel Group Placebo Controlled Clinical Trial of S-Ibuprofen Effects on TxB2 Concentrations and Platelet Aggregation in Aspirin-treated Healthy Adult Volunteers
Status:
COMPLETED
Status Verified Date:
2012-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this clinical trial is to determine whether S-ibuprofen affect the platelet inhibition under steady state acetylsalicylic acid conditions
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| EUDRACT 2006-002159-33 | None | None | None |